A cardiologist in Nagpur performs two similar angioplasties. But the stents inside his patients tell two very different stories. One gets Indian-made devices under a government scheme. The other insists on an imported brand.
This contrast is now common across India. Price caps pushed foreign stent makers into a corner in 2017. But they never left.
And now, they’re back with new valves, pacemakers, and high-margin cardiac devices. Domestic players, meanwhile, grew fast but still struggle with data, technology, and trust.
Tune in.
Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.
Join The Ken as a Podcast Producer and work with India's most ambitious storytellers! We’re creating a podcast about India’s biggest companies, with each episode backed by weeks of deep research. You’ll lead the workflows that turn that research into exceptional narratives and bring the show to listeners around the world. Join us to help shape something exceptional. Check out the details and apply here.
